The anti-inflammatory cytokine level (rat IL-10) in BALF in BPD rats was more effectively reduced by PTX3 siRNA MSC than by treatment with naïve MSCs or control siRNA-treated MSCs (Figure 5(g)). The gene discussed is PTX3; the disease is bronchopulmonary dysplasia.